These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25809413)

  • 1. Daily prednisone treatment in Duchenne muscular dystrophy in southwest China.
    Hu J; Ye Y; Kong M; Hong S; Cheng L; Wang Q; Qin J; Zou L; Jiang L
    Muscle Nerve; 2015 Dec; 52(6):1001-7. PubMed ID: 25809413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial.
    Beenakker EA; Fock JM; Van Tol MJ; Maurits NM; Koopman HM; Brouwer OF; Van der Hoeven JH
    Arch Neurol; 2005 Jan; 62(1):128-32. PubMed ID: 15642859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel treatment regimen for Duchenne muscular dystrophy.
    Li M; Cai Y; Zhong M; Zou L; Gong C
    Neuroreport; 2013 Nov; 24(16):924-7. PubMed ID: 24045777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative muscle ultrasound in children with Duchenne muscular dystrophy: Comparing to magnetic resonance imaging.
    Hu J; Jiang L; Hong S; Cheng L; Wang Q; Peng X; Qin J; Zou L
    J Clin Ultrasound; 2023 May; 51(4):674-679. PubMed ID: 36449321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.
    Escolar DM; Hache LP; Clemens PR; Cnaan A; McDonald CM; Viswanathan V; Kornberg AJ; Bertorini TE; Nevo Y; Lotze T; Pestronk A; Ryan MM; Monasterio E; Day JW; Zimmerman A; Arrieta A; Henricson E; Mayhew J; Florence J; Hu F; Connolly AM
    Neurology; 2011 Aug; 77(5):444-52. PubMed ID: 21753160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
    Balaban B; Matthews DJ; Clayton GH; Carry T
    Am J Phys Med Rehabil; 2005 Nov; 84(11):843-50. PubMed ID: 16244521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prednisone treatment in Duchenne muscular dystrophy.
    Merlini L; Cicognani A; Malaspina E; Gennari M; Gnudi S; Talim B; Franzoni E
    Muscle Nerve; 2003 Feb; 27(2):222-7. PubMed ID: 12548530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone therapy in Becker's muscular dystrophy.
    Johnsen SD
    J Child Neurol; 2001 Nov; 16(11):870-1. PubMed ID: 11732779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
    Connolly AM; Schierbecker J; Renna R; Florence J
    Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
    ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
    Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy.
    Jansen M; van Alfen N; Nijhuis van der Sanden MW; van Dijk JP; Pillen S; de Groot IJ
    Neuromuscul Disord; 2012 Apr; 22(4):306-17. PubMed ID: 22133654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
    Guglieri M; Clemens PR; Perlman SJ; Smith EC; Horrocks I; Finkel RS; Mah JK; Deconinck N; Goemans N; Haberlova J; Straub V; Mengle-Gaw LJ; Schwartz BD; Harper AD; Shieh PB; De Waele L; Castro D; Yang ML; Ryan MM; McDonald CM; Tulinius M; Webster R; McMillan HJ; Kuntz NL; Rao VK; Baranello G; Spinty S; Childs AM; Sbrocchi AM; Selby KA; Monduy M; Nevo Y; Vilchez-Padilla JJ; Nascimento-Osorio A; Niks EH; de Groot IJM; Katsalouli M; James MK; van den Anker J; Damsker JM; Ahmet A; Ward LM; Jaros M; Shale P; Dang UJ; Hoffman EP
    JAMA Neurol; 2022 Oct; 79(10):1005-1014. PubMed ID: 36036925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
    Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR
    Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy.
    Parreira SL; Resende MB; Della Corte Peduto M; Marie SK; Carvalho MS; Reed UC
    Arq Neuropsiquiatr; 2007 Jun; 65(2A):245-50. PubMed ID: 17607422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.
    Uzark K; King E; Cripe L; Spicer R; Sage J; Kinnett K; Wong B; Pratt J; Varni JW
    Pediatrics; 2012 Dec; 130(6):e1559-66. PubMed ID: 23129083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
    Escolar DM; Buyse G; Henricson E; Leshner R; Florence J; Mayhew J; Tesi-Rocha C; Gorni K; Pasquali L; Patel KM; McCarter R; Huang J; Mayhew T; Bertorini T; Carlo J; Connolly AM; Clemens PR; Goemans N; Iannaccone ST; Igarashi M; Nevo Y; Pestronk A; Subramony SH; Vedanarayanan VV; Wessel H;
    Ann Neurol; 2005 Jul; 58(1):151-5. PubMed ID: 15984021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.